Mersana Therapeutics, Inc.
MRSN
Revenue
2.29M
▼-6.95M▼-75.20%
3 Months ChangeAssets
179.13M
▼-19.25M▼-9.70%
3 Months ChangeLiabilities
170.70M
▲313.00k▲0.1837%
3 Months ChangeFree Cash Flow
-32.79M
▼-2.87M▼-9.60%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-13
Form 10-Q
ID: 0001628280-24-036864
2024-08-13
Form 8-K
ID: 0001104659-24-088640
2024-06-11
Form 8-K
ID: 0001104659-24-070408
2024-05-09
Form 10-Q
ID: 0001628280-24-021985
2024-05-09
Form 8-K
ID: 0001104659-24-059104
2024-02-28
Form 8-K
ID: 0001104659-24-028715
2024-02-28
Form 8-K
ID: 0001104659-24-028467
2024-01-05
Form 8-K
ID: 0001104659-24-001627
2023-12-21
Form 8-K
ID: 0001104659-23-128209
2023-11-07
Form 10-Q
ID: 0001628280-23-037193